Citation Impact
Citing Papers
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors
1999 StandoutNobel
Current Controlled Trials: an opportunity to help improve the quality of clinical research
2000
Role of the Frank-Starling mechanism in maintaining cardiac output during increasing levels of treadmill exercise in beta-blocked normal men
1989
Comparison of Two Methods to Detect Publication Bias in Meta-analysis
2006 Standout
The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials
2001 Standout
Why we need easy access to all data from all clinical trials and how to accomplish it
2011
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Optimal Pharmacologic and Non-pharmacologic Management of Cardiac Transplant Candidates: Approaches to Be Considered Prior to Transplant Evaluation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006
2006
Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials
2002
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Outcome based subgroup analysis: a neglected concern
2009
Successes and failures of current treatment of heart failure
1998
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Myocarditis
2011 Standout
Effect of Vitamin D on Falls
2004 Standout
Effects of a meal on hemodynamic function at rest and during exercise in patients with hypertrophic cardiomyopathy
1991
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay
2001 Standout
Reporting bias in medical research - a narrative review
2010
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Hypertrophic Cardiomyopathy
2002 Standout
Enoximone
1991
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Ventilatory mechanisms of exercise intolerance in chronic heart failure
1992
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope
1988
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Registering Clinical Trials
2003
Exercise limitation in chronic heart failure: Central role of the periphery
1996
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
What is the ideal study design for evaluation of treatment for heart failure?: Insights from trials assessing the effect of ACE inhibitors on exercise capacity
1996
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Myocarditis
2006 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO
2011
Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
1989
Clinical pharmacology, physiology and pathophysiology of superficial veins‐2.
1994
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
2009 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart Failure
1988
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001 Standout
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
1995 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
Publication and related biases.
2000
Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators.
1994
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Captopril in heart failure. A double blind controlled trial.
1984
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
Works of K. Stainer being referenced
Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.
1988
The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias
1993
Exercise tolerance in patients with heart failure—how should it be measured?
1991
Exercise capability in heart failure: is cardiac output important after all?
1991
EFFECTS OF CAPTOPRIL ON ABNORMALITIES OF THE PERIPHERAL CIRCULATION AND RESPIRATORY FUNCTION IN PATIENTS WITH SEVERE HEART FAILURE
1984
A NON-INVASIVE METHOD FOR MEASURING CARDIAC OUTPUT: THE EFFECT OF CHRISTMAS LUNCH
1986
Effects of food on the central and peripheral haemodynamic response to upright exercise in normal volunteers.
1990
Comparison of the effects of captopril and enoximone in patients with severe heart failure: a placebo controlled double-blind study
1989
Abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure.
1986
Effects of enoximone in patients with heart failure uncontrolled by captopril and diuretics
1990
SYMPTOMATIC ASSESSMENT OF PATIENTS WITH HEART FAILURE: DOUBLE-BLIND COMPARISON OF INCREASING DOSES OF DIURETICS AND CAPTOPRIL IN MODERATE HEART FAILURE
1986
CAPTOPRIL THERAPY FOR HEART FAILURE
1982